Professional Documents
Culture Documents
tmpFB45 TMP
tmpFB45 TMP
TE
PL
WOUNDS 2012;24(10):283288
IC
N
O
iabetic foot ulcers (DFU) are estimated to effect 15% of all individuals with diabetes during their lifetime and precede almost 85% of all
foot amputations.1,2 They are the most common, disabling, and costly
complications of diabetes. Diabetic foot wounds become easily infected due
to several factors including suppressed immunity, inadequate blood supply,
and neuropathy. Infection of a diabetic foot is one of the key contributing
factors to morbidity and to a majority of lower limb amputations. It is further
complicated by anaerobic pathogens resulting in delayed wound healing.The
increase in resistance among anaerobic pathogens poses a problem in the
Vol. 24, No. 10 October 2012
283
Aherrao et al
Keypoints
Methods
TE
PL
Metronidazole has become a choice among clinicians for eradication of anaerobic infection. The
decision regarding management of anaerobic infection in a diabetic foot with specific therapy like
Metronidazole is still a matter of debate.4
This study was designed to detect prevalence of
anaerobic infection using PCR technique, and to
evaluate if Metronidazole is making a difference in
healing of DFU that detect positive for anaerobes.
IC
N
O
284
WOUNDS www.woundsresearch.com
Keypoints
PL
IC
TE
Aherrao et al
N
O
Figure 3. Amplification of Peptostreptococcus productus Lanes 1-5: 1-DF2, 2-DF4, 3-DF9, 4-DF10, and
5-DF13. M-50bp ladder.
Results
Out of 61 patients, 32 (52%) had evidence of anaerobic
infection as detected by PCR, while only 5 (8%) were detected to have anaerobes by conventional culture methods. In the present study of 32 cases, Clostridium was
found with maximum prevalence of 24 (75%), followed
by Bacteroides with 17 (53.1%), and Peptostreptococcus
Keypoints
At the end of 16 weeks of followup, in the 17-patient Metronidazole group, 13 (76.5%) were found
to have complete healing of the wound, whereas in
the 15-patient non-Metronidazole group, 12 (80%)
had complete healing. There was no statistically significant difference in the treatment outcome in both
groups (P = 1, Fishers exact probability).
Vol. 24, No. 10 October 2012
285
Aherrao et al
Table 1. Comparison of baseline characteristics and the healing outcome of Metronidazole and nonMetronidazole treatment groups.
Distribution of age
Distribution of Sex
Non-Metronidazole
group
(Mean 2 SD)
(n = 15)
55.29 9.11
51.67 9.14
4 (23.5%)
3 (20%)
Female
Male
12 (80%)
1.000
(Fishers Exact
probability)
Grade 4
8 (47.1%)
5 (33.3%)
Grade 5
3 (17.6%)
3 (20%)
24.76 + 2.14
24.35 + 2.41
0.62
7.71 5.03
5.67 3.87
0.21
69.53 61.51
89.00 48.26
0.33
0.70 0.23
0.75 0.33
0.64
130.59 13.39
136.00 8.28
0.19
Diastolic
79.41 9.66
81.87 6.61
0.42
Hb level (g/l)
78.39 15.0
82.13 14.24
0.48
0.68
177.47 85.79
144.38 61.94
0.23
27.33 4.22
0.58
0.43
11
Creatinine (mol/L)
12
Albumin (g/L)
28.41 6.28
13
Calcium (mmol/L)
1.88 0.19
1.86 0.20
0.75
14
0.12 0.02
0.11 0.02
0.24
15
12 (80%)
4 (23.5%)
3 (20%)
1.000
(Fishers Exact probability)
10
N
O
Systolic
7 (46.7%)
PL
6 (35.3%)
0.27
Grade 3
13 (76.4%)
Statistical
significance
(P value)
TE
Metronidazole group
(Mean 2 SD)
(n = 17)
Characteristics
IC
Serial No.
Healed
Non-healed
286
WOUNDS www.woundsresearch.com
Aherrao et al
TE
N
O
PL
There is a need for continuous surveillance of resistant bacteria to provide the basis for empirical therapy
and reduce the risk of complications. This study was
completed to determine prevalence of anaerobes in diabetic foot infections and actual consistency of effects
of Metronidazole in healing of DFU. Diabetic foot infections are usually polymicrobial in nature due to aerobic
bacteria (Staphylococcus spp., Streptococcus sp., Enterobacteriaceae), anaerobic bacteria (Bacteroides spp.,
Clostridium spp., Peptostretococcus spp.) and fungi.6,7
Conventional culture methods have long been used
to identify bacteria in diabetic foot wounds. Culture results usually reveal a single organism,8 and sometimes
even fail to demonstrate organisms, despite other clinical evidences of infection. Unfortunately, results of cultures are generally not available for at least 2-3 days.9
Polymerase chain reaction methods have made it possible to detect most species of pathogens in the wound
in a matter of hours rather than days. Polymerase chain
reaction is also able to detect much smaller concentrations of microorganisms than standard cultures and
establish involvement of multiple organisms.10 Also,
previous antibiotic therapy is much less likely to cause
false-negative results with PCR than with the standard
culture. Thus, being more reliable than the traditional
culture method, PCR can be routinely used and could
revolutionize how clinicians utilize antimicrobials
against increasingly diverse and resistant pathogens.
The clinical characteristics of patients with anaerobic foot infections do not differ significantly
from those without, except that their prevalence increases with a higher Wagner Ulcer Classification
Grade. Thus, a high index of suspicion is needed for
diabetic foot infections classified as a Wagner Grade
3.3. Clostridium was the most frequently identified anaerobe across all Wagner grades, followed
by Bacteroides and Peptostreptococcus productus,
whereas earlier studies showed higher prevalence of
Peptostreptococcus spp.3 An association was noted between Clostridium infection, duration of DFU, and total leukocyte count; the study findings suggested that
advancing age of a wound increased the risk of Clostridium infection; however, the authors did not observe any kind of association of the other 2 anaerobes
(ie, Bacteriodes and Peptostreptococcus productus)
The authors interpret the results to mean Metronidazole is not mandatory for treatment of DFU with
anaerobic infection, assuming antibiotics given for
control of the aerobic infection are effective over
the anaerobes in the wound.
The strength of this studys observation relies on
the fact that the authors only randomized cases
into 2 groups that were detected positive for anaerobic infection by PCR, and did not differ in
terms of clinical and biochemical characteristics
at baseline; thus, ascertainment bias should not
be a concern in this data.
Discussion
Keypoints
IC
statistically significant difference in the treatment outcome in both groups (P = 1, Fishers exact probability).
287
Aherrao et al
Conclusion
8.
Acknowledgements
2.
N
O
3.
Lipsky BA. Evidence-based antibiotic therapy of diabetic foot infections. FEMS Immunol Medical Microbiol. 1999;26:267-276.
Deresinski S. Infections in the diabetic patient: Strategies for the clinician. Infectious Disease Reports.
1995;1(1): 1-12.
Colayco CAS, Mendoza MT, Alejandria MM, Ang CF.
Microbiologic and clinical profile of anaerobic diabetic foot infections. Phil J Microbiol Infect Dis.
2002;31:151-160.
Lofmark S, Edlund C, Nord CE Metronidazole is still
the drug of choice for treatment of anaerobic infections. Clin Infect Dis. 2010;50:1623.
Rekha R, Rizvi MA , Jaishree P. Designing and validation of genus-specific primers for human gut flora
study. Electron J Biotechnol. 2006;9:505-511.
Candel Gonzalez FJ, Alramadan M, Matesanz M, et
al.Infections in diabetic foot ulcers. Eur J Intern Med.
2003;14:341-343.
Chincholikar DA, Pal RB. Study of fungal and bacterial
infections of the diabetic foot. Indian J Pathol Microbiol. 2002;45:15-22.
1.
References
PL
The authors would like to thank Dr. Sameer Prabhakar from the Department of General Surgery for support with biopsy sample collection, and Dr. Archisman
Mohapatra from the Department of Preventive and
Social Sciences, Institute of Medical Science, Banaras
Hindu University for support with statistical analysis
of data. The authors also wish to express their gratitude to the Department of Biotechnology, Banaras
Hindu University, and to the patients who participated in the study.
TE
IC
This study demonstrated the significance of a molecular technique like PCR in detection of microbes in
DFU.This finding could have further implications on the
diagnosis and management of DFU in a cost-effective
manner. It was also observed that in a DFU, antibiotics
given for the control of aerobic infection were sufficient
for the control of anaerobes as well. Metronidazole is
not necessary for the eradication of anaerobic infection
in DFU. This would reduce the cost of foot care in resource-constrained areas.
4.
5.
6.
7.
288
WOUNDS www.woundsresearch.com